China has officially designated artificial intelligence, robotics, and innovative pharmaceuticals as its “next new three” strategic industries, signaling a major shift in the country’s economic and export strategy. The announcement, reported by Global Times, was made by Science and Technology Minister Yin Hejun and outlines Beijing’s vision for the next phase of its technological and industrial development, succeeding the previous “new three” of electric vehicles (EVs), lithium batteries, and solar panels.
This strategic pivot reflects China’s ambition to move up the global value chain and establish dominance in the industries that will define the 21st-century economy. By focusing on AI, robotics, and biotech, Beijing aims to create new engines of economic growth, enhance its global competitiveness, and reduce its reliance on traditional manufacturing and export sectors.
The Rationale Behind the Shift
The transition from the “new three” (EVs, batteries, solar) to the “next new three” is driven by several factors. First, while China has achieved global dominance in the previous strategic sectors, these industries are increasingly facing headwinds, including overcapacity, intensifying international competition, and rising trade barriers in key markets like the US and Europe.
Second, the “next new three” represent the frontier of technological innovation. Artificial intelligence is transforming every aspect of the economy, from manufacturing to services. Robotics is essential for addressing China’s demographic challenges, including an aging population and a shrinking workforce. Innovative pharmaceuticals are critical for improving public health and capturing a share of the lucrative global biotech market.
By prioritizing these sectors, China is positioning itself to lead the next wave of industrial revolution. The government is expected to provide substantial support to these industries, including financial subsidies, tax incentives, and favorable regulatory policies, to accelerate their development and global expansion.
The Rise of Chinese AI
Artificial intelligence is at the core of China’s new strategic vision. The country has made massive investments in AI research and development, and these efforts are beginning to bear fruit. Chinese tech giants and startups are rapidly developing advanced AI models that rival those produced by Western companies.
The scale of China’s AI adoption is staggering. According to recent data, Chinese large models registered 36.11 trillion token calls in the week of July 13–19, 2026, representing a 30.93% increase and marking eight consecutive weeks of growth. This explosive growth in AI usage highlights the rapid integration of AI technologies into various sectors of the Chinese economy.
The government’s focus on AI extends beyond domestic adoption. China is actively promoting the export of its AI technologies, including software, models, and infrastructure. This strategy aims to establish Chinese AI standards globally and create new revenue streams for domestic tech companies. The recent release of the open-weight Kimi K3 model by Moonshot AI is a prime example of this approach, offering a powerful alternative to Western proprietary models.
Robotics: Automating the Future
Robotics is another key pillar of the “next new three.” China is already the world’s largest market for industrial robots, and the government is now pushing for the development of more advanced and versatile robotic systems, including collaborative robots (cobots) and humanoid robots.
The export of Chinese robotics is growing rapidly. In the first half of 2026, robotics exports reached 6.29 billion yuan, reaching 141 countries. Notably, the export of high-end surgical robots increased by 3.3 times year-on-year, demonstrating China’s growing capabilities in sophisticated medical technology.
The push for robotics is driven by both economic and demographic imperatives. As labor costs rise and the workforce shrinks, automation is essential for maintaining China’s manufacturing competitiveness. Furthermore, the development of advanced robotics creates new opportunities in sectors such as healthcare, logistics, and services.
Innovative Drugs: A Global Ambition
The inclusion of innovative pharmaceuticals in the “next new three” highlights China’s ambition to become a major player in the global biotech industry. Historically, China’s pharmaceutical sector has focused on producing generic drugs, but the government is now heavily incentivizing the development of novel therapeutics.
This strategy is yielding significant results. In the first half of 2026, outbound licensing deals for Chinese pharmaceuticals reached $110 billion, indicating strong international interest in Chinese biotech innovations. Chinese companies are increasingly partnering with global pharmaceutical giants to bring their drugs to international markets.
The focus on innovative drugs is critical for addressing the healthcare needs of China’s aging population and reducing reliance on imported medications. It also represents a significant economic opportunity, as the global market for novel therapeutics continues to grow rapidly.
Challenges and Opportunities
While the “next new three” strategy presents significant opportunities for China, it also faces substantial challenges. The development of advanced AI, robotics, and pharmaceuticals requires massive investments in research and development, as well as a highly skilled workforce.
Furthermore, China’s ambitions in these sectors are likely to face resistance from other major economies, particularly the United States. The US has already implemented strict export controls on advanced semiconductors and AI technologies, and it may seek to restrict China’s access to critical components and markets in the robotics and biotech sectors.
Despite these challenges, China’s commitment to the “next new three” is clear. The government’s strategic focus, combined with the country’s massive market scale and growing technological capabilities, makes it a formidable competitor in these critical industries. The success of this strategy will have profound implications for the global economy and the balance of technological power in the 21st century.